ID Business Solutions
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ID Business Solutions - overview
Established
1989
Location
Guildford, -, UK
Primary Industry
Software
About
ID Business Solutions delivers innovative laboratory informatics solutions, providing enterprise software-as-a-service (SaaS) and consulting services tailored to the bio-pharmaceutical lifecycle, enhancing compliance and data management. Founded in 1989 in Guildford, UK, ID Business Solutions specializes in laboratory informatics solutions. The company has maintained a consistent focus on bio-pharmaceutical industries without significant pivots in strategy. Igor Goulart and Neil Kipling serve as the CEOs, guiding the firm towards success with their extensive backgrounds in technology and consulting.
IDBS specializes in comprehensive laboratory informatics solutions, delivering enterprise software-as-a-service (SaaS) and consulting services tailored for the bio-pharmaceutical lifecycle, from research and development (R&D) through to manufacturing. Their core offerings include products such as E-WorkBook for data management, PIMS for manufacturing processes, and tools designed for bioprocessing and cell line development. These solutions facilitate compliant workflows, automate business processes, integrate diverse data types, and enhance visibility across experiments, addressing critical needs such as data integrity, quality, and regulatory compliance in GxP environments. IDBS serves a diverse clientele, including 15 of the top 20 global biopharmaceutical companies, focusing on markets across North America, Europe, and Asia, where they aim to improve data-driven decision-making and accelerate time-to-market for life-changing therapies.
IDBS generated revenue of USD 46. 44 mn in 2023, with an EBITDA of USD -3. 41 mn. The company primarily relies on subscription-based models for its software solutions and consulting services, engaging clients in multi-year contracts that streamline laboratory processes and ensure compliance with industry regulations.
IDBS's revenue structure is characterized by partnerships with biopharma organizations and direct transactions with contract research organizations (CROs) and manufacturing entities, supported by robust customer loyalty and long-term relationships. Future growth plans for IDBS include the introduction of new products aimed at enhancing laboratory informatics capabilities. The company is also exploring expansion into additional geographic markets, specifically targeting regions in Asia and South America by the end of 2024. Recent funding will be strategically utilized to support the development of these upcoming products and to enhance market penetration in the identified regions.
Primary Industry
Software
Sub Industries
Analytics & Performance Software
Website
www.idbs.com
Total Amount Raised
Subscriber access only
ID Business Solutions - timeline of key events
ID Business Solutions - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 30,174,821 | 28,557,301 | 31,047,374 | 30,339,287 | 27,057,080 | 26,654,543 | 30,425,329 | 22,318,703 | 24,312,557 | 27,730,047 | 31,380,687 | 28,291,199 | - | - | - |
| % Revenue Growth (YoY) | - | (5.4%) | 8.7% | (2.3%) | (10.8%) | (1.5%) | 14.1% | (26.6%) | 8.9% | 14.1% | 13.2% | (9.8%) | - | - | - |
| EBITDA (USD) | 5,828,348 | (1,845,445) | (327,334) | (3,205,450) | (366,047) | (994,253) | 3,225,291 | (3,226,957) | 1,577,334 | 4,088,605 | 5,432,452 | (1,931,875) | - | - | - |
| Operating Income (USD) | 5,127,843 | (2,623,928) | (1,112,250) | (3,974,579) | (1,302,973) | (1,339,848) | 2,895,454 | (3,384,490) | 1,493,428 | 3,510,151 | 5,136,342 | (2,128,732) | - | - | - |
| Operating Margin | 17.0% | (9.2%) | (3.6%) | (13.1%) | (4.8%) | (5.0%) | 9.5% | (15.2%) | 6.1% | 12.7% | 16.4% | (7.5%) | - | - | - |
| % EBITDA Margin | 19.3% | (6.5%) | (1.1%) | (10.6%) | (1.4%) | (3.7%) | 10.6% | (14.5%) | 6.5% | 14.7% | 17.3% | (6.8%) | - | - | - |
| NET Income (USD) | 3,858,159 | (2,582,624) | (981,588) | (3,760,567) | (1,456,832) | (1,089,950) | 2,452,135 | (3,050,052) | 8,675,352 | 3,573,779 | 5,241,594 | (2,081,304) | - | - | - |
| % Net Margin | 12.8% | (9.0%) | (3.2%) | (12.4%) | (5.4%) | (4.1%) | 8.1% | (13.7%) | 35.7% | 12.9% | 16.7% | (7.4%) | - | - | - |
ID Business Solutions - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.